MED15 involved in head and neck squamous cell carcinoma

April 2, 2015
MED15 involved in head and neck squamous cell carcinoma

(HealthDay)—The mediator subunit MED15 appears to be involved in head and neck squamous cell carcinoma (HNSCC), according to a study published in the April issue of The American Journal of Pathology.

Zaki Shaikhibrahim from the University Hospital of Bonn in Germany, and colleagues examined the role of MED15 in HNSCC. They performed immunohistochemistry for MED15 on 324 tissue samples. MED15 knockdown was also performed, followed by proliferation and migration assays, as was transforming growth factor-β-1 (TGF-β1) treatment followed by MED15 analysis.

The researchers found that MED15 was overexpressed in 35, 30, and 70 percent of primary tumors, lymph node metastases, and recurrences, respectively, compared with no or low expression in . In primary tumors from patients who developed recurrences, MED15 overexpression correlated with elevated mortality rates and was seen at the highest frequency in oral cavity or oropharyngeal tumors. There was a correlation for MED15 expression between primary tumors and corresponding . TGF-β activity in tissues was associated with MED15; TGFβ activation led to increased MED15 expression and decreased pSMAD3 on MED15 knockdown.

"Taken together, our results implicate MED15 in HNSCC and hint that MED15 overexpression is a clonal event during HNSCC progression," the authors write. "MED15 may serve as a for recurrence and as a therapeutic target."

Explore further: Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma

March 20, 2015
A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated ...

Periodontitis linked to HPV-positive head, neck tumors

June 20, 2012
(HealthDay) -- For patients with head and neck squamous cell carcinoma (HNSCC) there is an increased risk of human papillomavirus (HPV)-positive tumors among those with a history of periodontitis, according to a study published ...

Sensitizing tumor cells to radiotherapy

March 1, 2012
Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer worldwide. Tumor resistance to radio- and/or chemotherapy remains a significant clinical problem.

New radiotracer helps avoid neck dissection in patients with early head and neck cancer

February 13, 2015
The discovery that the identification and biopsy of the first lymph node to which a cancer spreads (the sentinel node) can lead to more accurate diagnosis and treatment has revolutionised the management of breast cancer. ...

Comprehensive genomic analysis identifies alterations in head and neck cancer that could lead to targeted therapy

April 8, 2013
Not all head and neck squamous cell carcinomas (HNSCCs) have the same pattern of genomic alterations, but those cancers with certain distinctive patterns could be amenable to specific targeted therapies, according to a researcher ...

Recommended for you

Single-cell study in a childhood brain tumor affirms the importance of context

April 20, 2018
In defining the cellular context of diffuse midline gliomas, researchers find the cells fueling their growth and suggest a potential approach to treating them: forcing their cells to be more mature.

Aggressive breast cancer already has resistant tumour cells prior to chemotherapy

April 20, 2018
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center ...

Mechanism that drives development of liver cancer brought on by non-alcoholic fatty liver disease discovered

April 19, 2018
A team of researchers from several institutions in China has found a mechanism that appears to drive the development of a type of liver cancer not caused by alcohol consumption. In their paper published in the journal Science ...

Discovery adds to evidence that some children are predisposed to develop leukemia

April 19, 2018
St. Jude Children's Research Hospital researchers have made a discovery that expands the list of genes to include when screening individuals for possible increased susceptibility to childhood leukemia. The finding is reported ...

Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past

April 19, 2018
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that procedure, doctors insert a bone-biopsy needle through an ...

Scientists identify 170 potential lung cancer drug targets using unique cellular library

April 19, 2018
After testing more than 200,000 chemical compounds, UT Southwestern's Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.